栄研化学(株)の貸借残高情報
| 主市場 | 業種 | 証券コード/EDINET | 英名称 |
|---|
| 東証PRM | 医薬品 | 4549/E00961 | - |
| 公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
|---|
| 2015/08/28 | 日証協 | 135,558株 | +0.59% | 11,140株 | -87.13% | 79,293株 | -0.38% | 13,910株 | +7.83% |
| 2015/08/21 | 日証協 | 134,758株 | -0.72% | 86,541株 | -15.19% | 79,593株 | +1.02% | 12,900株 | +31.57% |
| 2015/08/14 | 日証協 | 135,739株 | -3.04% | 102,039株 | -42.81% | 78,793株 | -15.08% | 9,805株 | -2.16% |
| 2015/08/07 | 日証協 | 139,999株 | +3.68% | 178,413株 | +214.11% | 92,780株 | -4.9% | 10,021株 | +9.99% |
| 2015/07/31 | 日証協 | 135,030株 | -8.79% | 56,800株 | -47.68% | 97,563株 | -0.61% | 9,111株 | -90.32% |
| 2015/07/24 | 日証協 | 148,050株 | +71.45% | 108,560株 | +430.6% | 98,158株 | +134.11% | 94,100株 | +2933.53% |
| 2015/07/17 | 日証協 | 86,350株 | +10.24% | 20,460株 | +132.5% | 41,928株 | -1.64% | 3,102株 | -2.79% |
| 2015/07/10 | 日証協 | 78,331株 | -0.13% | 8,800株 | -63.35% | 42,626株 | -15.95% | 3,191株 | -53.07% |
| 2015/07/03 | 日証協 | 78,431株 | -11.41% | 24,014株 | -18.77% | 50,716株 | -14.07% | 6,800株 | -67.32% |
| 2015/06/26 | 日証協 | 88,531株 | -1.71% | 29,562株 | +44.56% | 59,017株 | -17.05% | 20,810株 | +116.68% |
| 2015/06/19 | 日証協 | 90,070株 | -9.86% | 20,449株 | +326.02% | 71,148株 | -12.98% | 9,604株 | +40.9% |
| 2015/06/12 | 日証協 | 99,918株 | -6.73% | 4,800株 | -90.62% | 81,759株 | -3.41% | 6,816株 | -81.12% |
| 2015/06/05 | 日証協 | 107,133株 | +10.13% | 51,156株 | +54.54% | 84,643株 | +17.98% | 36,104株 | +61.45% |
| 2015/05/29 | 日証協 | 97,280株 | 0% | 33,103株 | 0% | 71,743株 | 0% | 22,362株 | 0% |
| 2015/05/15 | 日証協 | 142,196株 | +8.41% | 26,124株 | -44.87% | 135,053株 | +11.77% | 9,924株 | +125.55% |
| 2015/05/08 | 日証協 | 131,160株 | -26.79% | 47,387株 | -20.42% | 120,829株 | -23.03% | 4,400株 | -59.3% |
| 2015/05/01 | 日証協 | 179,148株 | -3.35% | 59,548株 | -37.78% | 156,986株 | -10.79% | 10,810株 | -76.59% |
| 2015/04/24 | 日証協 | 185,363株 | +19.28% | 95,703株 | +4.25% | 175,976株 | +11.73% | 46,177株 | +4.94% |
| 2015/04/17 | 日証協 | 155,401株 | +42.44% | 91,803株 | +28.6% | 157,504株 | +8.85% | 44,005株 | -6.97% |
※株式分割は考慮していませんのでご注意ください。
Page Top